Scheme 1. Synthesis of the Substrate
access to a variety of dibenzo[a,c]cycloheptenes.10 MoCl5
is a versatile reagent for the oxidative transformation of
arenes11 whichtoleratesnumerousfunctionalgroups12 and
prefers a specific substitution pattern on the aryl moiety.13
In the course of the reaction, hydrogen chloride is liberated
from the reagent. In order to keep the reaction mixture
electrophilic and active, Lewis acids can be used for
binding the hydrogen chloride.14 The reagent waste con-
sists of electrophilic metal chlorides which form multi-
nuclear clusters and may serve as templates in a stereo-
selective oxidative coupling process.15
Here we report an oxidative coupling sequence which
does not stop at the intramolecular arylation product but,
rather, proceeds with further C-H functionalization. In a
one-pot procedure, carboxymethyl fragments can also be
installed upon oxidative cyclization. The synthesis of the
substrate 2 commenced with phosphono acetate 1. After
deprotonation and installation of the first aryl moiety via a
benzylation, the second aryl group was introduced, using a
Horner-Wadsworth-Emmons olefination. Compound
2, prepared in a modular fashion, was formed in an E/Z
ratio of 3:1 (Scheme 1).
Treatment of 2 with MoCl5/TiCl4 in CH2Cl2 not only
affected the aryl-aryl bond formation but also brought
about oxidation of the central cycloheptatriene system (3)
to the tropylium intermediate 4. Benzo annulations on
bonds a and c of the seven-membered ring usually desta-
bilize a tropylium system since the planar geometry is
difficult to maintain.16 However, trapping such a reactive
intermediate with a carbonyl oxygen provides 5 which
forms a 1,5-diene system (6) in the presence of a base. This
might undergo a [3,3]-sigmatropic rearrangement leading
to the observed product 7.
Figure 1. Structures of metasequirin-B, alllocolchicine, and
steganacine.
eight-membered ring system, also binds to the colchicine
binding site on tubulin.5
Among the naturally occurring norcycloneolignans
metasequrin-B is the only known natural product with a
bisbenzocycloheptene skeleton fused to a tetrahydrofuran
system. It was isolated from the heartwood of Metasequoia
glyptostroboides.6 The close structural relationship of
metasequirin-B to the well investigated allocolchicine, as
well as steganacine (Figure 1), promises an interesting
pharmacological profile. The described tubulin-binding
compounds are classified as vascular disrupting agents be-
cause of their mechanism of action. In contrast to anti-
angiogenesis drugs, the vascular disrupting agents act on
existing blood vessels that feed a solid tumor resulting in
tumor ischemia and necrosis. Such drugs offer a nonsurgi-
cal treatment in the case of advanced disease which is of
major interest in cancer therapy.7 Most synthetic ap-
proaches construct the biaryl intermediate at an early
stage, and the central seven-membered ring is subsequently
formed. Synthetic efforts to these tricyclic architectures
usually require many steps.8
Despite the atom economic nature of oxidative coupling
reactions, the direct conversion ofthe corresponding diaryl
substrates via this technology has not received much atten-
tion due to the low yields that are usually observed for such
reactions.9
Use of the powerful oxidant MoCl5 provides, in the
conversion of 1,3-diaryl propanes, a fast and modular
If the workup was performed with an ethyl acetate/
triethyl amine mixture the ethyloxycarbonylmethyl-
modified product 8 was isolated in 70% yield (Table 1,
entry 1). An increased steric demand in the alkyl portion
of the ester has little influence (entry 2). The strong
electrophilic reaction conditions promote elimination of
secondary alkyl moieties. Therefore, other auxiliaries
had to be applied but showed no diastereoselectivity
ꢀ
(5) (a) Joncour, A.; Decor, A.; Liu, J. M.; Tran Huu Dau, M. E.;
Baudoin, O. Chem.;Eur. J. 2007, 13, 5450. (b) Wang, R. W.; Rebhuhn,
L. I.; Kupchan, S. M. Cancer Res. 1977, 37, 3071.
(6) (a) Enoki, A.; Takahama, S.; Kitao, K. Chem. Abstr. 1978, 88,
71429. (b) Sanceau, J. Y.; Dhal, R.; Brown, E. Nat. Prod. Lett. 1992, 221.
(7) Lippert, J. W. Bioorg. Med. Chem. 2007, 15, 605.
(8) Graening, T.; Schmalz, H. G. Angew. Chem., Int. Ed. 2004, 43,
3230.
(9) Scott, A. I. Nature 1960, 186, 556.
(10) Kramer, B.; Waldvogel, S. R. Angew .Chem. Int. Ed. 2004, 43,
2446.
(13) (a) Mirk, D.; Waldvogel, S. R. Tetrahedron Lett. 2004, 45, 7911.
(b) Waldvogel, S. R. Synlett 2002, 622.
€
(14) Kramer, B.; Frohlich, R.; Waldvogel, S. R. Eur. J. Org. Chem.
(11) (a) Spurg, A.; Schnakenburg, G.; Waldvogel, S. R. Chem.;Eur.
J. 2009, 15, 13313. (b) Rempala, P.; Kroulik, J.; King, B. T. J. Org.
Chem. 2006, 71, 5067. (c) King, B. T.; Kroulik, J.; Robertson, C. R.;
Rempala, P.; Hilton, C. L.; Korinek, J. D.; Gortari, L. M. J. Org. Chem.
2007, 72, 2279.
2003, 3549.
(15) Boshta, N.; Bomkamp, M.; Schnakenburg, G.; Waldvogel, S. R.
Chem.;Eur. J. 2010, 16, 3459. Boshta, N.; Bomkamp, M.; Schnakenburg,
G.; Waldvogel, S. R. Eur. J. Org. Chem. 2011in press.
(16) (a) Cook, J. W.; Dickson, G. T.; Loudon, J. D. J. Chem. Soc.
1947, 746. (b) Dewar, M. J.; Ganellin, C. R. J. Chem. Soc. 1959, 3139. (c)
Pomerantz, M.; Dassanayake, N. L.; Mc Manus, T. R.; Reynolds, C. H.
J. Org. Chem. 1984, 49, 4029.
€
(12) (a) Waldvogel, S. R.; Frohlich, R.; Schalley, C. A. Angew.
Chem., Int. Ed. 2000, 39, 2472. (b) Waldvogel, S. R.; Wartini, A. R.;
Rasmussen, P. H.; Rebek, J. Tetrahedron Lett. 1999, 40, 3515. (c)
€
Waldvogel, S. R.; Aits, E.; Holst, C.; Frohlich, R. Chem. Commun.
€
2002, 1278. (d) Kramer, B.; Frohlich, R.; Bergander, K.; Waldvogel,
S. R. Synthesis 2003, 91.
Org. Lett., Vol. 13, No. 5, 2011
917